BOLT — Bolt Biotherapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- $45.75m
- -$56.44m
- $7.88m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -30.5 | -60.7 | -98.6 | -88.1 | -69.2 |
Depreciation | |||||
Non-Cash Items | 1.54 | 15.1 | 19.8 | 13 | 7.68 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.27 | -2.28 | 20.5 | -3.06 | -9.86 |
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -26.3 | -47.3 | -57.1 | -76.5 | -69.5 |
Capital Expenditures | -0.508 | -3.26 | -2.34 | -1.95 | -0.206 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | -17.3 | -230 | 59.8 | 71.2 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.508 | -20.6 | -232 | 57.9 | 71 |
Financing Cash Flow Items | 48.6 | 39.3 | 0 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 48.6 | 39.6 | 311 | 0.503 | 0.253 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 21.8 | -28.3 | 21.8 | -18.1 | 1.77 |